Polymorphism | Genotype | N | TBARS concentration [μmol/L] | p a (ANOVA) | p b (vs wild type homozygote) |
---|---|---|---|---|---|
GPX1 (rs1050450) | Pro/Pro | 148 | 2.32 (1.80–3.09) | 0.0527 |  |
Pro/Leu | 136 | 2.15 (1.69–2.64) | |||
Leu/Leu | 35 | 2.29 (1.75–2.94) | |||
Pro/Leu + Leu/Leu | 171 | 2.18 (1.70–2.73) |  | 0.0320 | |
GPX4 (rs713041) | CC | 109 | 2.23 (1.82–2.85) | 0.4266 |  |
CT | 156 | 2.21 (1.75–2.89) | |||
TT | 54 | 2.38 (1.86–3.07) | |||
CT + TT | 210 | 2.34 (1.76–2.94) |  | 0.3237 | |
SEPP1 (rs3877899)c | Ala/Ala | 203 | 2.26 (1.76–2.94) | 0.9393 |  |
Ala/Thr | 99 | 2.21 (1.74–2.87) | |||
Thr/Thr | 15 | 2.05 (1.65–2.93) | |||
Ala/Thr + Thr/Thr | 114 | 2.19 (1.74–2.87) |  | 0.7802 | |
SEP15 (rs5859) | GG | 185 | 2.26 (1.78–2.93) | 0.8028 |  |
GA | 112 | 2.22 (1.69–2.92) | |||
AA | 22 | 2.03 (1.75–2.86) | |||
GA + AA | 134 | 2.21 (1.73–2.89) |  | 0.5357 | |
SOD2 (rs4880) | Ala/Ala | 79 | 2.32 (178–3.00) | 0.8902 |  |
Ala/Val | 167 | 2.23 (1.76–2.87) | |||
Val/Val | 73 | 2.22 (1.69–2.92) | |||
 | Ala/Val + Val/Val | 240 | 2.23 (1.74–2.88) |  | 0.6891 |